I do think a buy out of the Patent is diffidently going to happen here. So much progress has been achieved to get to this stage. The question is how much is this worth ? We know R & D cost many £10's M's and years of companies time and effort. £25-£50M ? would still be very cheap considering the scale and sole patent of this product.
Some info for the markets to wake up too. Once the filed licence gets the approval, production will commence. This product is massive, can't see M/C at this level for much longer. Only 81.56M shares in issue. Even at 30p that's only a M/C of @ £24M. Plenty cash in the bank too. Letter from the CEO:
With the successful conclusion of last year's acquisition of IVIX LLC ("IVIX") and the re-admission of the enlarged group on Euronext Dublin and the London Stock Exchange, the foundation was put in place for establishing Ovoca as a recognized developer of novel therapeutics for women's health, especially in the area of sexual dysfunction. Our colleagues at IVIX continue to build out our successful BP101 program, which you will have seen in March 2019 comfortably exceeded the efficacy and safety hurdles in its Phase 3 trial in Russia. As a result, we are now preparing to file for the drug's marketing approval in its first country, the Russian Federation, and actively pursuing discussions with potential licensing partners to commercialize there.
Boris Reznik, chairman of Biorasi added: "We are very excited to begin this project with Ovoca/IVIX. Their BP-101 drug candidate has shown promising performance in clinical trials so far, and we believe there is high potential in bringing it over to the EU and US markets."
Just need to listen to the May 2019 podcast.... There are some key points when the Name change gets completed which it has. 1. DS... stated more contracts in the pipeline in a couple of months ( Its now July ! new contracts to be announced imminently ) 2.JQ... Stated companies have been asking them to finalise & complete contracts that have already been written ( More contracts ) 3.DS... The really big contracts will be in Q3 as they been in negotiations since Jan ( which is this period ) 4.These Guys turn £200 to £17M 5. They stated a £1M contract will be done by the end of that month ( This was confirmed ) So with 4 & 5 are facts , you can trust these guys to deliver 1,2 & 3.
What we have now is a new direction forward with in essence a shell company bought by the new owners, All issues that as arisen with the old stem cell company and its debts has been dealt with within WDC placing / funding. This was cleverly done with the huge discounted 0.3p placing from 1p share at that time. This revenue was and has been and still been sorting all issues before this name change. Now with existing previous shareholders that have no interest in the new company have been selling all their shares hence why we have seen such constant selling over the last 2-3 weeks. This is over now ( maybe a few more left ) but with a fresh clean start on Monday 15th July 2019 and with the £1M contract in place to kick in, We will see the start of a recovering SP. This £1M contract alone match its current M/C. Over the last 4-6weeks we know the new directors have been in the USA promoting and negotiating their services to their clients. There was no legal statement that prevented our new guys that sold their old company not approaching their old clients to start expanding ICON portfolio of clients. ICON have a new product that is so advanced of all its competitors that once we receive news of this which they will announced when the new name change is done. We will really see the SP move north. I am expecting news imminently with further signed multiples of £1M contracts , and news of what ICONIC LABS new inventive platform is all about. These guys have had this idea which they have kept secret until they are ready to release to the markets. Meanwhile this new idea has been presented to new clients and we await confirmation. This is going to be a very exciting year with so much progress being announced and expecting the SP to move quickly first to 0.5p then closer to 1p on news. GLA
Most of the selling over the last few weeks are the holders of the old WDC ( stem cells investors ) Knowingly the name change happening they are no longer interested to the new companies direction ( ICONIC LABS ) If they had shares at 0.25p they are still making a profit. All we are seeing is the final sell off. Hence why the delay in the company name change. Once all these have gone, The New company can start releasing its contracts and update of progress. Don't forget the boys were negotiating further new contracts last month and stated that nothing more will be released until the New Name change.
Wild Card.. I think the bid was actually 0.27 offer 0.28 even thou the computers some time can not decide wether buys/sells in the value. Earlier on my screen it clearly shows 0.27 bid offer 0.29p ... hence why most or all 0.28 was seen as sells.
just pick up a few more 0.288 is my buy show as a sell There have been 1.5M buy 0.29 shows as sell too. Investors getting spooked and selling, This new company will have new contracts announced and further updates expecting on Monday. My gut feeling this will open at 0.4p on Monday with name change.
Chrispye84 Thanks for the update date. Did they mention the company will reconsolidate the number of shares in issue ? This will make sense and move us away from the penny share syndrome that new investors may tarnish us with.
There's not many Aim companies that are fully funded for the next 2 years. BigDish can maintain a low number of shares without any dilution during this period. Last placing was 7.2p. The next placing in 2 years times ( if they need it ) will be over excess of £1